Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY,
RELATED STOCKHOLDERS’ MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
MARKET INFORMATION AND HOLDERS
The Company’s Common Stock trades in the over-the-counter
market under the symbol RLBY. The high and low sale prices for 2024 and 2023 are set forth below. High and low price is based on the highest
and lowest intraday or closing prices recorded during the entire quarter,
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
2024
High
$
0.0800
$
0.0451
$
0.0990
$
0.0970
Low
$
0.0800
$
0.0451
$
0.0914
$
0.0695
2023
High
$
0.0590
$
0.0425
$
0.0549
$
0.0550
Low
$
0.0590
$
0.0425
$
0.0549
$
0.0550
The Company paid no cash dividends in 2023 or 2024.
As of March 17, 2025, the last reported sales price
for Company Common Stock was $0.0350 per share.
As of December 31,2024, there were 513 holders of
record of Company Common Stock.
EQUITY COMPENSATION PLANS
None
RECENT SALES OF UNREGISTERED SECURITIES
None
SHARE REPURCHASES
None
ITEM 6. SELECTED FINANCIAL DATA
The following tables set forth our summary of consolidated
historical financial data. You should read the information set forth below in conjunction with “Item 7. Management’s Discussion
and Analysis of Financial Condition and Results of Operations” and our consolidated historical financial statements and notes thereto
included elsewhere in this Annual Report on Form 10-K. The statement of operations data for the fiscal years ended 2024 and 2023 and the
balance sheet data as of December 31, 2024 and 2023 set forth below are derived from our audited consolidated financial statements included
elsewhere in this Annual Report on Form 10-K.
December 31,
Balance Sheet Data:
2024
2023
Working capital
$ 7,296
$ 7,913
Total assets
$ 11,556
$ 9,786
Total outstanding borrowings, net
$ 2,375
$ 174
Total other long-term liabilities
$ 21
$ -
Stockholders’ equity
$ 7,337
$ 7,931
27
December 31,
Statement of Operation Data:
2024
2023
Revenues
$ 23,982
$ 21,451
Gross profit
3,192
3,039
Selling, general and administrative expenses
3,899
3,788
Operating loss
(707 )
(749 )
Interest income
18
25
Interest income from related parties
452
269
Interest expense
(108 )
(92 )
Other income (expense)
(249 )
(179 )
Income (loss) before income taxes
(594 )
(726 )
Income tax benefit (expense)
-
(14 )
Net income (loss)
$ (594 )
$ (740 )
December 31,
Net Income (Loss) Per Share:
2024
2023
Net income (loss) per share – basic
$ .00
$ .00
Net income (loss) per share – diluted
$ .00
$ .00
Weighted average shares outstanding – basic
300,000,000
300,000,000
Weighted average shares outstanding – diluted
300,000,000
300,000,000
December 31,
Other Financial Data:
2024
2023
OIBITDA (1)
$ 2
$ 57
(1) We present OIBITDA as a measure that
is not in accordance with generally accepted accounting principles (“non-GAAP”), in this Annual Report on Form 10-K to provide
investors with a supplemental measure of our operating performance. We believe that OIBITDA is a useful performance measure and is employed
by us to facilitate comparisons of our operating performance on a consistent basis from period-to-period and to provide for a more complete
understanding of factors and trends affecting our core business than measures under generally accepted accounting principles (“GAAP”)
can provide alone. Our board and management also use OIBITDA as some of the primary methods for planning and forecasting overall expected
performance and for evaluating on a quarterly and annual basis actual result against such expectations, and as a performance evaluation
metric in determining achievement of certain compensation programs and plans for our management and organization.
We define OIBITDA as operational earnings before interest
expense, related party interest, income taxes, depreciation and amortization expense, loss on early extinguishment of debt and related
party debt, transaction fees and costs related to our corporate overhead which consist mainly of costs associated with being a public
company. Omitting interest, taxes and the other items provides a financial measure that facilitates comparisons of our results of operations
with those of companies having different capital structures. Since the levels of indebtedness and tax structures that other companies
have are different from ours, we omit these amounts to facilitate investors’ ability to make like comparisons. Similarly, we omit
depreciation and amortization because many other companies likely employ a greater amount of property and intangible assets. We omit “corporate”
or non-operating costs as they are meant to be allocated against a larger operational base which our business plan outlines. As we grow
our operations organically and through M&A activities these corporate costs are absorbed more equitably, we will use Earnings Before
Interest, Taxes, Depreciation and Amortization (“EBITDA”) as our means of measuring comparable operational performance to
other companies in our industry. We also believe that investors, analysts, and other interested parties view our ability to generate OIBITDA
as an important measure of our operating performance and that of other companies in our industry. OIBITDA should not be considered as
an alternative to net income (loss) for the periods indicated as a measure of our performance.
28
The use of OIBITDA has limitations as analytical tools,
and you should not consider these performance measures in isolation from, or as an alternative to, GAAP measures such as net income (loss).
OIBITDA is not a measure of liquidity under GAAP or otherwise and is not an alternative to cash flow from continuing operating activities.
Our presentation of OIBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are
excluded from that term or by unusual or non-recurring items. The limitations of OIBITDA include: (i) it does not reflect our corporate
expenditures or future requirements for capital expenditures or contractual commitments; (ii) it does not reflect changes in, or cash
requirements for, our working capital needs; (iii) it does not reflect income tax payments we may be required to make; and (iv) it does
not reflect the cash requirements necessary to service interest or principal payments associated with indebtedness.
To properly and prudently evaluate our business, we
encourage you to review our consolidated financial statements included elsewhere in this Annual Report on Form 10-K and the reconciliation
to OIBITDA from net income (loss), the most directly comparable financial measure presented in accordance with GAAP, set forth in the
following table. All the items included in the reconciliation from net income (loss) to OIBITDA are either (i) corporate costs or (ii)
items that management does not consider in assessing our on-going operating performance. In the case of the other items that management
does not consider in assessing our on-going operating performance, management believes that investors may find it useful to assess our
operating performance if the measures are presented without these items because their financial impact may not reflect on-going operating
performance.
OIBITDA calculation comparison for the years ended
December 31, 2024 and 2023 are as follows:
December 31,
2024
2023
Operating income (loss)
$ (707 )
$ (749 )
Depreciation and amortization
23
18
Sales, general, and administrative
686
788
$ 2
$ 57
Operational performance comparison for the years ended
December 31, 2024 and 2023 are as follows:
December 31,
2024
2023
Revenue
$ 23,982
$ 21,451
Gross profit
$ 3,192
$ 3,039
OIBITDA
$ 2
$ 57
Net income (loss)
$ (594 )
$ (740 )
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.